Master of Pharmaceutical Sciences has two course of study track options: 1) a thesis-based track; and 2) a capstone track.
Core Courses (23 credits)
- MPS 501 Introduction to Pharmaceutical Sciences I (3 CR)
- MPS 502 Techniques in Pharmaceutical Sciences: Theory and Practice (2 CR)
- MPS 505 Graduate Seminar (1 CR)
- MPS 511 Introduction to Pharmaceutical Sciences II (3 CR)
- MPS 512 Principal of FDA Regulatory Affairs and Drug Discovery (3 CR)
- MPS 513 Biostatistics & Research Methods (3 CR)
- MPS 514 Clinical Biochemistry (3 CR)
- MPS 515 medical immunology (3 CR)
- MPS 518 Advances in drug delivery (2 CR)
Thesis Courses
- MPS 506 Research and Thesis Part I (3 CR)
- MPS 516 Research and Thesis Part II (3 CR)
Elective Courses (2 credits)
A minimum of 2 credits are required.
Core Courses (25 credits)
- MPS 501 Introduction to Pharmaceutical Sciences I (3 CR)
- MPS 507 Capstone Paper I (3 CR)
- MPS 517 Capstone Paper II (3 CR)
- MPS 511 Introduction to Pharmaceutical Sciences II (3 CR)
- MPS 502 Techniques in Pharmaceutical Sciences: Theory and Practice (2 CR)
- MPS 512 Principal of FDA Regulatory Affairs
Elective Courses (2 credits)
A minimum of 2 credits are required.Elective Course Options (Subject to Change)
- MPS 601 Advanced Topics in Drug Design (2 CR)
- MPS 602 Advanced Topics in Phytochemistry (2 CR)
- MPS 603 Advanced Topics in Immunology (2 CR)
- MPS 604 Journal Seminar (2 CR)
The 2+4 MPS+MD (Master of Pharmaceutical Sciences + Doctor of Medicine) combined program (aka pathway) at California Northstate University is designed to offer a unique opportunity (pathway) for students to enter into medical school. This combined program will significantly increase the chances to enter into medical school, receiving competitive clinical residencies and pursue career opportunities in advanced medicine. For this MPS-MD combined program, the students must maintain a cumulative GPA of 3.5 in the MPS program and required MCAT score to be matriculated into the MD program.